Patients' goals when initiating long-acting injectable buprenorphine treatment for opioid use disorder: findings from a longitudinal qualitative study.

IF 3 3区 医学 Q2 SUBSTANCE ABUSE Substance Abuse Treatment, Prevention, and Policy Pub Date : 2023-06-22 DOI:10.1186/s13011-023-00551-0
Joanne Neale, Stephen Parkin, John Strang
{"title":"Patients' goals when initiating long-acting injectable buprenorphine treatment for opioid use disorder: findings from a longitudinal qualitative study.","authors":"Joanne Neale, Stephen Parkin, John Strang","doi":"10.1186/s13011-023-00551-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Long-acting injectable buprenorphine (LAIB) is a new treatment for opioid use disorder that has been introduced against an international policy backdrop of recovery and person-centred care. This paper explores the goals that people want to achieve from LAIB to identify potential implications for policy and practice.</p><p><strong>Methods: </strong>Data derive from longitudinal qualitative interviews conducted with 26 people (18 male; 8 female) initiating LAIB in England and Wales, UK (June 2021-March 2022). Participants were interviewed up to five times by telephone over six months (107 interviews in total). Transcribed interview data relating to each participant's treatment goals were coded, summarised in Excel, and then analysed via a process of Iterative Categorization.</p><p><strong>Results: </strong>Participants often articulated a desire to be abstinent without defining exactly what they meant by this. Most intended to reduce their dosage of LAIB but did not want to rush. Although participants seldom used the term 'recovery', almost all identified objectives consistent with current definitions of this concept. Participants articulated broadly consistent goals over time, although some extended the timeframes for achieving treatment-related goals at later interviews. At their last interview, most participants remained on LAIB, and there were reports that the medication was enabling positive outcomes. Despite this, participants were aware of the complex personal, service-level, and situational factors that hindered their treatment progress, understood the additional support they needed to achieve their goals, and voiced frustrations when services failed them.</p><p><strong>Conclusions: </strong>There is a need for wider debate regarding the goals people initiating LAIB are seeking and the diverse range of positive treatment outcomes LAIB could potentially generate. Those providing LAIB should offer regular on-going contact and other forms of non-medical support so that patients have the best opportunity to succeed. Policies relating to recovery and person-centred care have previously been criticised for responsibilising patients and service users to take better care of themselves and to change their own lives. In contrast, our findings suggest that these policies may, in fact, be empowering people to expect a greater range of support as part of the package of care they receive from service providers.</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":"18 1","pages":"37"},"PeriodicalIF":3.0000,"publicationDate":"2023-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288705/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Substance Abuse Treatment, Prevention, and Policy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13011-023-00551-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Long-acting injectable buprenorphine (LAIB) is a new treatment for opioid use disorder that has been introduced against an international policy backdrop of recovery and person-centred care. This paper explores the goals that people want to achieve from LAIB to identify potential implications for policy and practice.

Methods: Data derive from longitudinal qualitative interviews conducted with 26 people (18 male; 8 female) initiating LAIB in England and Wales, UK (June 2021-March 2022). Participants were interviewed up to five times by telephone over six months (107 interviews in total). Transcribed interview data relating to each participant's treatment goals were coded, summarised in Excel, and then analysed via a process of Iterative Categorization.

Results: Participants often articulated a desire to be abstinent without defining exactly what they meant by this. Most intended to reduce their dosage of LAIB but did not want to rush. Although participants seldom used the term 'recovery', almost all identified objectives consistent with current definitions of this concept. Participants articulated broadly consistent goals over time, although some extended the timeframes for achieving treatment-related goals at later interviews. At their last interview, most participants remained on LAIB, and there were reports that the medication was enabling positive outcomes. Despite this, participants were aware of the complex personal, service-level, and situational factors that hindered their treatment progress, understood the additional support they needed to achieve their goals, and voiced frustrations when services failed them.

Conclusions: There is a need for wider debate regarding the goals people initiating LAIB are seeking and the diverse range of positive treatment outcomes LAIB could potentially generate. Those providing LAIB should offer regular on-going contact and other forms of non-medical support so that patients have the best opportunity to succeed. Policies relating to recovery and person-centred care have previously been criticised for responsibilising patients and service users to take better care of themselves and to change their own lives. In contrast, our findings suggest that these policies may, in fact, be empowering people to expect a greater range of support as part of the package of care they receive from service providers.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿片类药物使用障碍患者开始接受长效注射丁丙诺啡治疗时的目标:一项纵向定性研究的结果。
背景:长效注射用丁丙诺啡(LAIB)是一种治疗阿片类药物使用障碍的新疗法,它是在康复和以人为本的国际政策背景下引入的。本文探讨了人们希望从 LAIB 中实现的目标,以确定对政策和实践的潜在影响:数据来源于对英国英格兰和威尔士(2021 年 6 月至 2022 年 3 月)的 26 名 LAIB 患者(18 名男性;8 名女性)进行的纵向定性访谈。参与者在六个月内接受了最多五次电话访谈(共 107 次访谈)。与每位参与者的治疗目标相关的访谈记录数据均已编码,并在Excel中汇总,然后通过迭代分类法进行分析:结果:受试者通常都表达了禁欲的愿望,但并没有明确说明禁欲的具体含义。大多数人打算减少 LAIB 的用量,但又不想操之过急。虽然参与者很少使用 "康复 "一词,但几乎所有人都确定了与这一概念的当前定义相一致的目标。尽管有些参与者在后来的访谈中延长了实现治疗相关目标的时间框架,但他们所阐述的目标在一段时间内大体一致。在最后一次访谈中,大多数参与者仍在服用 LAIB,有报告称药物治疗带来了积极的结果。尽管如此,参与者还是意识到阻碍其治疗进展的复杂的个人、服务层面和情境因素,了解实现目标所需的额外支持,并在服务失败时表达了挫败感:有必要就开始 LAIB 的人所追求的目标以及 LAIB 有可能产生的各种积极治疗结果进行更广泛的讨论。提供 LAIB 的机构应提供定期的持续联系和其他形式的非医疗支持,以便患者获得成功的最佳机会。与康复和以人为本的护理相关的政策曾被批评为要求病人和服务使用者更好地照顾自己并改变自己的生活。与此相反,我们的研究结果表明,这些政策实际上可能赋予了人们更多的权力,使他们能够期望获得更多的支持,作为他们从服务提供者那里获得的一揽子护理服务的一部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.20
自引率
0.00%
发文量
73
审稿时长
19 weeks
期刊介绍: Substance Abuse Treatment, Prevention, and Policy is an open access, peer-reviewed journal that encompasses research concerning substance abuse, with a focus on policy issues. The journal aims to provide an environment for the exchange of ideas, new research, consensus papers, and critical reviews, to bridge the established fields that share a mutual goal of reducing the harms from substance use. These fields include: legislation pertaining to substance use; correctional supervision of people with substance use disorder; medical treatment and screening; mental health services; research; and evaluation of substance use disorder programs.
期刊最新文献
Enhancing the drug addiction treatment service by introducing a new residential treatment model in the Philippines: A qualitative study. COVID-19 public health restrictions and opioid overdoes: a summative content analysis of emergency medical services records in three Texas counties. The relationship between insecure attachment and nicotine dependence among users of classic cigarettes, e-cigarettes, and heated tobacco products: a moderated mediation model. Access and barriers to safer supply prescribing during a toxic drug emergency: a mixed methods study of implementation in British Columbia, Canada. Initiation and/or re-initiation of drug use among people who use drugs in Vancouver, Canada from 2021 to 2022: a prospective cohort study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1